Triamterene

Generic name: Pronounced as (trye am' ter een)
Brand names
  • Dyrenium®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 06/15/2017

Triamterene is used alone or with other medications to treat edema (fluid retention; excess fluid held in body tissues) caused by various conditions, including liver and heart disease. Triamterene is in a class of medications called diuretics ('water pills'). It causes the kidneys to eliminate unneeded water and sodium from the body into the urine, but reduces the loss of potassium.

Triamterene comes as a capsule to take by mouth. It usually is taken once a day in the morning after breakfast or twice a day after breakfast and lunch. It is best to take triamterene earlier in the day so that frequent trips to the bathroom do not interfere with nighttime sleep. Take triamterene at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take triamterene exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Triamterene is used in combination with other diuretics to treat high blood pressure.

This medicine may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking triamterene,

  • tell your doctor and pharmacist if you are allergic to triamterene or any other medications (Dyazide, Maxzide).

  • do not take triamterene if you are taking amiloride (Midamor), spironolactone (Aldactone), or other medications containing triamterene.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril, (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik); lithium (Eskalith, Lithobid); nonsteroidal anti-inflammatory medications (NSAIDS) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); medications for diabetes, or high blood pressure; other diuretics; and potassium supplements. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had diabetes, gout, kidney stones, or heart, kidney, or liver disease.

  • tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking triamterene, call your doctor. Do not breastfeed if you are taking triamterene.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking triamterene.

  • plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen. Triamterene may make your skin sensitive to sunlight.

Follow your doctor's directions for your meals, including advice for a reduced salt (sodium) diet and daily exercise program. Avoid potassium-containing salt substitutes while you are taking this medication..Talk with your doctor about the amount of potassium-rich foods (e.g., bananas, prunes, raisins, and orange juice) that you may have in your diet.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Triamterene may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • vomiting

    • dizziness

    • headache

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

    • muscle weakness or cramps

    • slow or irregular heartbeat

    • diarrhea

    • rash

    • difficulty breathing or swallowing

    • upset stomach

    • extreme tiredness

    • unusual bleeding or bruising

    • lack of energy

    • loss of appetite

    • pain in the upper right part of the stomach

    • yellowing of the skin or eyes

    • flu-like symptoms

    • sore throat

    • severe dry mouth

    • unusual bruising or bleeding

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medicine in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • upset stomach

  • vomiting

  • weakness or tiredness

  • dizziness

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to triamterene.

Do not let anyone else take your medicine. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Triamterene can be decreased when combined with Moxifloxacin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Triamterene can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Triamterene can be decreased when it is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Triamterene can be decreased when combined with Nevirapine.
Alendronate Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Triamterene is combined with Alendronic acid.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Triamterene.
Anagrelide Anagrelide The metabolism of Triamterene can be decreased when combined with Anagrelide.
Bisacodyl Bisacodyl The risk or severity of adverse effects can be increased when Triamterene is combined with Bisacodyl.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Candesartan is combined with Triamterene.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Triamterene.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Triamterene.
Diphenoxylate Diphenoxylate The therapeutic efficacy of Triamterene can be decreased when used in combination with Diphenoxylate.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Triamterene can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate Triamterene may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Triamterene may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide Triamterene may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Magnesium Oxide Magnesium Oxide The risk or severity of adverse effects can be increased when Triamterene is combined with Magnesium oxide.
Mycophenolate Mycophenolate Triamterene may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Olsalazine Olsalazine The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olsalazine is combined with Triamterene.
Paregoric Paregoric The therapeutic efficacy of Triamterene can be decreased when used in combination with Morphine.
Penbutolol Penbutolol The risk or severity of hyperkalemia can be increased when Triamterene is combined with Acebutolol.
Pentazocine Pentazocine The therapeutic efficacy of Triamterene can be decreased when used in combination with Pentazocine.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The risk or severity of adverse effects can be increased when Triamterene is combined with Polyethylene glycol.
Potassium Potassium The risk or severity of hyperkalemia can be increased when Triamterene is combined with Potassium cation.
Prednisone Prednisone Triamterene may decrease the excretion rate of Prednisone which could result in a higher serum level.
Psyllium Psyllium The risk or severity of adverse effects can be increased when Triamterene is combined with Plantago seed.
Ranitidine Ranitidine The metabolism of Ranitidine can be decreased when combined with Triamterene.
Reserpine Reserpine Triamterene may decrease the excretion rate of Reserpine which could result in a higher serum level.
Rizatriptan Rizatriptan Triamterene may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Triamterene may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The risk or severity of hyperkalemia can be increased when Triamterene is combined with Tacrolimus.
Tiludronate Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Triamterene is combined with Etidronic acid.
Tizanidine Tizanidine The metabolism of Tizanidine can be decreased when combined with Triamterene.
Zolmitriptan Zolmitriptan The metabolism of Triamterene can be decreased when combined with Zolmitriptan.
Ampicillin Injection Ampicillin Injection Triamterene may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Triamterene may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Famotidine Injection Famotidine Injection The metabolism of Triamterene can be decreased when combined with Famotidine.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Triamterene which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection The therapeutic efficacy of Triamterene can be decreased when used in combination with Hydromorphone.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Triamterene can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Triamterene can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Triamterene can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Triamterene can be increased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection Triamterene may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Morphine Injection Morphine Injection The therapeutic efficacy of Triamterene can be decreased when used in combination with Morphine.
Pamidronate Injection Pamidronate Injection The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Triamterene.
Vancomycin Injection Vancomycin Injection Triamterene may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may increase the orthostatic hypotensive activities of Triamterene.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefuroxime.
Cyclosporine Cyclosporine The risk or severity of hyperkalemia can be increased when Triamterene is combined with Cyclosporine.
Ondansetron Ondansetron The metabolism of Triamterene can be decreased when combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Triamterene is combined with Enoxaparin.
Torsemide Torsemide The risk or severity of adverse effects can be increased when Triamterene is combined with Torasemide.
Olanzapine Olanzapine The metabolism of Triamterene can be decreased when combined with Olanzapine.
Alosetron Alosetron The metabolism of Triamterene can be decreased when combined with Alosetron.
Dofetilide Dofetilide The serum concentration of Dofetilide can be increased when it is combined with Triamterene.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Triamterene.
Meloxicam Meloxicam The therapeutic efficacy of Triamterene can be decreased when used in combination with Meloxicam.
Pantoprazole Pantoprazole Triamterene may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Triamterene is combined with Risedronic acid.
Telmisartan Telmisartan The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Triamterene.
Temozolomide Temozolomide Triamterene may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Triamterene may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Triamterene can be increased when combined with Anakinra.
Linezolid Linezolid Linezolid may increase the orthostatic hypotensive activities of Triamterene.
Etanercept Injection Etanercept Injection The metabolism of Triamterene can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Triamterene can be increased when combined with Modafinil.
Perindopril Perindopril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Perindopril.
Tenofovir Tenofovir Triamterene may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Choline magnesium trisalicylate is combined with Triamterene.
Epinephrine Injection Epinephrine Injection The risk or severity of Cardiac Arrhythmia can be increased when Epinephrine is combined with Triamterene.
Eplerenone Eplerenone The risk or severity of hyperkalemia can be increased when Triamterene is combined with Eplerenone.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Triamterene.
Zonisamide Zonisamide Triamterene may decrease the excretion rate of Zonisamide which could result in a higher serum level.
Adalimumab Injection Adalimumab Injection The metabolism of Triamterene can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole Aripiprazole may increase the hypotensive activities of Triamterene.
Atomoxetine Atomoxetine Triamterene may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Atazanavir Atazanavir The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Atazanavir.
Almotriptan Almotriptan Triamterene may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The risk or severity of adverse effects can be increased when Triamterene is combined with Polyethylene glycol.
Vardenafil Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Triamterene.
Emtricitabine Emtricitabine Triamterene may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Triamterene can be decreased when combined with Interferon beta-1a.
Memantine Memantine Triamterene may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Triamterene can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Triamterene may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Triamterene.
Gemifloxacin Gemifloxacin The metabolism of Triamterene can be decreased when combined with Gemifloxacin.
Apomorphine Injection Apomorphine Injection The risk or severity of adverse effects can be increased when Triamterene is combined with Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Triamterene can be increased when combined with Infliximab.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Triamterene is combined with Duloxetine.
Tinidazole Tinidazole Triamterene may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan Triamterene may increase the hypotensive activities of Bosentan.
Cefditoren Cefditoren Triamterene may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Triamterene.
Cyanocobalamin Injection Cyanocobalamin Injection Triamterene may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Triamterene.
Eszopiclone Eszopiclone Triamterene may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir Triamterene may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Triamterene may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Valganciclovir Valganciclovir Triamterene may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Triamterene is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Adefovir.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the orthostatic hypotensive activities of Triamterene.
Entecavir Entecavir The metabolism of Entecavir can be decreased when combined with Triamterene.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Triamterene can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Triamterene can be increased when it is combined with Peginterferon alfa-2b.
Ibandronate Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Triamterene is combined with Ibandronate.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the orthostatic hypotensive activities of Triamterene.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Triamterene.
Fentanyl Fentanyl Triamterene may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin Pregabalin Triamterene may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Deferasirox Deferasirox The serum concentration of Triamterene can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The metabolism of Triamterene can be increased when combined with Phenylephrine.
Ranolazine Ranolazine Triamterene may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Abatacept Injection Abatacept Injection The metabolism of Triamterene can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the orthostatic hypotensive activities of Triamterene.
Imatinib Imatinib The metabolism of Imatinib can be decreased when combined with Triamterene.
Sitagliptin Sitagliptin Triamterene may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Triamterene may decrease the excretion rate of Varenicline which could result in a higher serum level.
Albuterol Albuterol Triamterene may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Triamterene may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Bortezomib Bortezomib The metabolism of Triamterene can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Triamterene may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Triamterene can be increased when combined with Insulin glulisine.
Lubiprostone Lubiprostone Triamterene may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Primaquine Primaquine The metabolism of Triamterene can be decreased when combined with Primaquine.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Triamterene is combined with Aliskiren.
Pemetrexed Injection Pemetrexed Injection Triamterene may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Triamterene is combined with Nabilone.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Triamterene.
Levocetirizine Levocetirizine Triamterene may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Triamterene may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Triamterene.
Mexiletine Mexiletine The metabolism of Triamterene can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The metabolism of Triamterene can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Triamterene may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The risk or severity of adverse effects can be increased when Triamterene is combined with Castor oil.
Lenalidomide Lenalidomide Triamterene may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Budesonide Budesonide Triamterene may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Triamterene may decrease the excretion rate of Desmopressin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Triamterene may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Triamterene may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine Triamterene may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Triamterene may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Nebivolol Nebivolol The risk or severity of hyperkalemia can be increased when Triamterene is combined with Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Triamterene is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Triamterene.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Triamterene.
Certolizumab Injection Certolizumab Injection The metabolism of Triamterene can be increased when combined with Certolizumab pegol.
Daptomycin Injection Daptomycin Injection Triamterene may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Triamterene.
Methylnaltrexone Injection Methylnaltrexone Injection Triamterene may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Midazolam Midazolam Triamterene may decrease the excretion rate of Midazolam which could result in a higher serum level.
Naltrexone Injection Naltrexone Injection The therapeutic efficacy of Triamterene can be decreased when used in combination with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Triamterene may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Triamterene.
Milnacipran Milnacipran Triamterene may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Triamterene may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate Triamterene may increase the nephrotoxic activities of Sodium phosphate, monobasic.
Fesoterodine Fesoterodine Triamterene may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol The metabolism of Triamterene can be decreased when combined with Betaxolol.
Prasugrel Prasugrel Triamterene may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The risk or severity of hyperkalemia can be increased when Triamterene is combined with Tolvaptan.
Pralatrexate Injection Pralatrexate Injection Triamterene may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Triamterene may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Triamterene may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Triamterene may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol The therapeutic efficacy of Triamterene can be decreased when used in combination with Tapentadol.
Topotecan Topotecan Triamterene may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Triamterene can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Triamterene.
Asenapine Asenapine The metabolism of Asenapine can be decreased when combined with Triamterene.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Triamterene.
Oxymorphone Oxymorphone The therapeutic efficacy of Triamterene can be decreased when used in combination with Oxymorphone.
Tocilizumab Injection Tocilizumab Injection The metabolism of Triamterene can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine Triamterene may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Ceftaroline fosamil.
Acetaminophen Injection Acetaminophen Injection The metabolism of Triamterene can be decreased when combined with Acetaminophen.
Ipilimumab Injection Ipilimumab Injection Triamterene may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Triamterene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Triamterene may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Triamterene.
Roflumilast Roflumilast Triamterene may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Potassium Iodide Potassium Iodide The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Triamterene.
Abiraterone Abiraterone The serum concentration of Triamterene can be increased when it is combined with Abiraterone.
Rivaroxaban Rivaroxaban Triamterene may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Triamterene may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Triamterene may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib Vemurafenib The serum concentration of Triamterene can be increased when it is combined with Vemurafenib.
Deferiprone Deferiprone Triamterene may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Triamterene.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Triamterene which could result in a higher serum level.
Ambrisentan Ambrisentan Triamterene may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Triamterene may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Iloprost Iloprost The risk or severity of adverse effects can be increased when Triamterene is combined with Iloprost.
Enzalutamide Enzalutamide Triamterene may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron Triamterene may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Linaclotide Linaclotide The risk or severity of adverse effects can be increased when Triamterene is combined with Linaclotide.
Teriflunomide Teriflunomide The serum concentration of Triamterene can be decreased when it is combined with Teriflunomide.
Teduglutide Injection Teduglutide Injection Triamterene may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin Alogliptin Triamterene may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Triamterene.
Canagliflozin Canagliflozin Triamterene may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Triamterene is combined with Methazolamide.
Trametinib Trametinib Triamterene may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Triamterene may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Triamterene may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Triamterene may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Triamterene.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Triamterene.
Ketorolac Injection Ketorolac Injection The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Triamterene.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Triamterene is combined with Obinutuzumab.
Simeprevir Simeprevir The metabolism of Triamterene can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Triamterene may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The metabolism of Triamterene can be decreased when combined with Dapagliflozin.
Apremilast Apremilast The metabolism of Triamterene can be increased when combined with Apremilast.
Droxidopa Droxidopa The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Triamterene.
Siltuximab Injection Siltuximab Injection The metabolism of Triamterene can be increased when combined with Siltuximab.
Belinostat Injection Belinostat Injection The metabolism of Triamterene can be increased when combined with Belinostat.
Testosterone Injection Testosterone Injection Triamterene may decrease the excretion rate of Testosterone which could result in a higher serum level.
Empagliflozin Empagliflozin Empagliflozin may increase the diuretic activities of Triamterene.
Hydrocodone Hydrocodone The therapeutic efficacy of Triamterene can be decreased when used in combination with Hydrocodone.
Edoxaban Edoxaban Triamterene may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Triamterene can be decreased when combined with Peginterferon beta-1a.
Methamphetamine Methamphetamine Triamterene may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Triamterene.
Riociguat Riociguat The risk or severity of adverse effects can be increased when Triamterene is combined with Riociguat.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Triamterene.
Secukinumab Injection Secukinumab Injection The metabolism of Triamterene can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Triamterene may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Triamterene can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The metabolism of Triamterene can be decreased when combined with Lenvatinib.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Triamterene is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The metabolism of Haloperidol can be decreased when combined with Triamterene.
Amiloride Amiloride The risk or severity of hyperkalemia can be increased when Triamterene is combined with Amiloride.
Macitentan Macitentan Triamterene may decrease the excretion rate of Macitentan which could result in a higher serum level.
Penicillin G Procaine Injection Penicillin G Procaine Injection Triamterene may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The therapeutic efficacy of Triamterene can be decreased when used in combination with Eluxadoline.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Triamterene can be increased when combined with Insulin degludec.
Osimertinib Osimertinib The serum concentration of Triamterene can be decreased when it is combined with Osimertinib.
Ixazomib Ixazomib Triamterene may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Triamterene may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Amphotericin B.
Brivaracetam Injection Brivaracetam Injection Triamterene may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Selexipag Selexipag Triamterene may increase the hypotensive activities of Selexipag.
Obeticholic Acid Obeticholic Acid The metabolism of Triamterene can be decreased when combined with Obeticholic acid.
Furosemide Injection Furosemide Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Furosemide.
Rucaparib Rucaparib The metabolism of Rucaparib can be decreased when combined with Triamterene.
Lixisenatide Injection Lixisenatide Injection Triamterene may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Triamterene.
Plecanatide Plecanatide The risk or severity of adverse effects can be increased when Triamterene is combined with Plecanatide.
Deutetrabenazine Deutetrabenazine Triamterene may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Triamterene may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide Safinamide Safinamide may increase the orthostatic hypotensive activities of Triamterene.
Naldemedine Naldemedine Triamterene may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Triamterene can be decreased when combined with Midostaurin.
Enasidenib Enasidenib The metabolism of Triamterene can be decreased when combined with Enasidenib.
Benznidazole Benznidazole Triamterene may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Triamterene may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Buprenorphine Injection Buprenorphine Injection The therapeutic efficacy of Triamterene can be decreased when used in combination with Buprenorphine.
Apalutamide Apalutamide Triamterene may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Triamterene.
Baricitinib Baricitinib Triamterene may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Triamterene.
Plazomicin Injection Plazomicin Injection Triamterene may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Triamterene.
Cannabidiol Cannabidiol The metabolism of Triamterene can be decreased when combined with Cannabidiol.
Stiripentol Stiripentol The metabolism of Triamterene can be decreased when combined with Stiripentol.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Triamterene is combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Triamterene can be decreased when combined with Rifamycin.
Prucalopride Prucalopride Triamterene may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Magnesium Citrate Magnesium Citrate The risk or severity of adverse effects can be increased when Triamterene is combined with Magnesium citrate.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Triamterene can be increased when combined with Emapalumab.
Acyclovir Ophthalmic Acyclovir Ophthalmic The metabolism of Acyclovir can be decreased when combined with Triamterene.
Solriamfetol Solriamfetol Triamterene may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Triclabendazole Triclabendazole The metabolism of Triamterene can be decreased when combined with Triclabendazole.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Triamterene.
Pitolisant Pitolisant Triamterene may decrease the excretion rate of Pitolisant which could result in a higher serum level.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Triamterene can be increased when combined with Fosphenytoin.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Triamterene.
Capmatinib Capmatinib The metabolism of Triamterene can be decreased when combined with Capmatinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Triamterene can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Triamterene is combined with Drospirenone.
Viloxazine Viloxazine Triamterene may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Triamterene may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Theophylline Theophylline The metabolism of Triamterene can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fenoprofen is combined with Triamterene.
Indomethacin Indomethacin Indomethacin may increase the nephrotoxic activities of Triamterene.
Mefenamic Acid Mefenamic Acid The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mefenamic acid is combined with Triamterene.
Naproxen Naproxen The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Naproxen is combined with Triamterene.
Tolmetin Tolmetin The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tolmetin is combined with Triamterene.
Sulindac Sulindac The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulindac is combined with Triamterene.
Isotretinoin Isotretinoin Triamterene may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Triamterene may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine Triamterene may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Phenobarbital Phenobarbital Phenobarbital may increase the hypotensive activities of Triamterene.
Metaxalone Metaxalone Triamterene may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Methotrexate.
Levorphanol Levorphanol The therapeutic efficacy of Triamterene can be decreased when used in combination with Levorphanol.
Primidone Primidone The metabolism of Triamterene can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of hyperkalemia can be increased when Triamterene is combined with Methsuximide.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Triamterene.
Diazepam Diazepam Triamterene may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Triamterene may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Triamterene may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Triamterene may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Triamterene may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The risk or severity of adverse effects can be increased when Triamterene is combined with Phenoxybenzamine.
Carmustine Carmustine The metabolism of Triamterene can be decreased when combined with Carmustine.
Amantadine Amantadine Triamterene may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Triamterene may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of adverse effects can be increased when Triamterene is combined with Bromocriptine.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the orthostatic hypotensive activities of Triamterene.
Phenelzine Phenelzine Phenelzine may increase the orthostatic hypotensive activities of Triamterene.
Procarbazine Procarbazine Procarbazine may increase the orthostatic hypotensive activities of Triamterene.
Tetracycline Tetracycline Triamterene may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Thioridazine Thioridazine The risk or severity of adverse effects can be increased when Triamterene is combined with Thioridazine.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Triamterene.
Bleomycin Bleomycin Triamterene may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Triamterene may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Oxycodone Oxycodone The therapeutic efficacy of Triamterene can be decreased when used in combination with Oxycodone.
Methadone Methadone The therapeutic efficacy of Triamterene can be decreased when used in combination with Methadone.
Benztropine Benztropine Triamterene may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Triamterene.
Ibuprofen Ibuprofen The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ibuprofen is combined with Triamterene.
Orphenadrine Orphenadrine The metabolism of Triamterene can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Perphenazine can be decreased when combined with Triamterene.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Triamterene.
Methylphenidate Methylphenidate Triamterene may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Sulfasalazine Sulfasalazine The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Sulfasalazine is combined with Triamterene.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Phenazopyridine.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be increased when combined with Triamterene.
Methyldopa Methyldopa Triamterene may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Triamterene.
Prazosin Prazosin The risk or severity of adverse effects can be increased when Triamterene is combined with Prazosin.
Hydralazine Hydralazine Triamterene may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Triamterene may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Triamterene may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin Triamterene may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Triamterene may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of hyperkalemia can be increased when Triamterene is combined with Loperamide.
Promethazine Promethazine Triamterene may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate Meclofenamate The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Triamterene.
Nitrofurantoin Nitrofurantoin Triamterene may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The metabolism of Triamterene can be increased when combined with Griseofulvin.
Digoxin Digoxin Triamterene may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Triamterene may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine Quinine The metabolism of Quinine can be decreased when combined with Triamterene.
Ethosuximide Ethosuximide The risk or severity of hyperkalemia can be increased when Triamterene is combined with Ethosuximide.
Lactulose Lactulose The risk or severity of adverse effects can be increased when Triamterene is combined with Lactulose.
Chlorothiazide Chlorothiazide The risk or severity of adverse effects can be increased when Triamterene is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Triamterene is combined with Chlorthalidone.
Metolazone Metolazone Triamterene may decrease the excretion rate of Metolazone which could result in a higher serum level.
Secobarbital Secobarbital Secobarbital may increase the hypotensive activities of Triamterene.
Desipramine Desipramine Triamterene may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline The metabolism of Triamterene can be decreased when combined with Amitriptyline.
Imipramine Imipramine The metabolism of Triamterene can be decreased when combined with Imipramine.
Probenecid Probenecid Triamterene may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine The metabolism of Quinidine can be decreased when combined with Triamterene.
Procainamide Procainamide Triamterene may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid The metabolism of Triamterene can be decreased when combined with Isoniazid.
Pyrazinamide Pyrazinamide Triamterene may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin The metabolism of Triamterene can be increased when combined with Rifampicin.
Disopyramide Disopyramide The metabolism of Triamterene can be decreased when combined with Disopyramide.
Valproic Acid Valproic Acid The metabolism of Triamterene can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Triamterene.
Butabarbital Butabarbital Triamterene may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Liothyronine Liothyronine Triamterene may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole The metabolism of Triamterene can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide Triamterene may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Tolbutamide Tolbutamide Triamterene may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Triamterene may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Triamterene.
Baclofen Baclofen Triamterene may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Triamterene may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Triamterene.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Triamterene is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Triamterene can be decreased when combined with Chlorzoxazone.
Pyridoxine Pyridoxine Triamterene may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Triamterene may decrease the excretion rate of Folic acid which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Triamterene.
Minoxidil Minoxidil The risk or severity of adverse effects can be increased when Triamterene is combined with Minoxidil.
Spironolactone Spironolactone The risk or severity of hyperkalemia can be increased when Triamterene is combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Amphotericin B.
Phytonadione Phytonadione Triamterene may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Triamterene may decrease the excretion rate of Amikacin which could result in a higher serum level.
Nadolol Nadolol Triamterene may decrease the excretion rate of Nadolol which could result in a higher serum level.
Butorphanol Injection Butorphanol Injection The therapeutic efficacy of Triamterene can be decreased when used in combination with Butorphanol.
Nalbuphine Injection Nalbuphine Injection The therapeutic efficacy of Triamterene can be decreased when used in combination with Nalbuphine.
Allopurinol Allopurinol Triamterene may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Flavoxate Flavoxate Triamterene may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Triamterene is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Triamterene.
Colchicine Colchicine Triamterene may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefaclor.
Cefadroxil Cefadroxil The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefadroxil.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefazolin.
Cephalexin Cephalexin The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cephalexin.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefoxitin.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Triamterene.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefotaxime.
Calcitonin Salmon Injection Calcitonin Salmon Injection Triamterene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Triamterene can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Triamterene may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of adverse effects can be increased when Triamterene is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of adverse effects can be increased when Triamterene is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Etacrynic acid.
Colistimethate Injection Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Colistimethate.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Triamterene which could result in a higher serum level.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Triamterene.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Triamterene which could result in a higher serum level.
Salsalate Salsalate The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salsalate is combined with Triamterene.
Alprazolam Alprazolam Triamterene may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Triamterene may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Triamterene may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Triamterene may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Triamterene may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Triamterene may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Diltiazem Diltiazem The risk or severity of hyperkalemia can be increased when Diltiazem is combined with Triamterene.
Nifedipine Nifedipine The metabolism of Nifedipine can be decreased when combined with Triamterene.
Timolol Timolol Timolol may decrease the excretion rate of Triamterene which could result in a higher serum level.
Verapamil Verapamil The metabolism of Verapamil can be decreased when combined with Triamterene.
Atenolol Atenolol The risk or severity of hyperkalemia can be increased when Atenolol is combined with Triamterene.
Pindolol Pindolol Triamterene may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Triamterene may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diflunisal is combined with Triamterene.
Piroxicam Piroxicam The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Piroxicam is combined with Triamterene.
Bumetanide Bumetanide The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Bumetanide.
Streptozocin Streptozocin The metabolism of Triamterene can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Triamterene.
Glipizide Glipizide Triamterene may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Triamterene may decrease the excretion rate of Indapamide which could result in a higher serum level.
Amoxicillin Amoxicillin Triamterene may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The metabolism of Triamterene can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Triamterene may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Triamterene.
Pentamidine Injection Pentamidine Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Ceftriaxone.
Labetalol Labetalol Triamterene may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin Auranofin Triamterene may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Triamterene may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil The metabolism of Triamterene can be decreased when combined with Gemfibrozil.
Guanabenz Guanabenz The metabolism of Guanabenz can be decreased when combined with Triamterene.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Adefovir dipivoxil.
Ceftazidime Injection Ceftazidime Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Ceftazidime.
Ketoprofen Ketoprofen The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Triamterene.
Cefotetan Injection Cefotetan Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefotetan.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Triamterene.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Flurbiprofen is combined with Triamterene.
Amiodarone Amiodarone The metabolism of Triamterene can be decreased when combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Triamterene may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Triamterene may decrease the excretion rate of Buspirone which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin The metabolism of Triamterene can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Mesalazine is combined with Triamterene.
Diclofenac Diclofenac The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Diclofenac is combined with Triamterene.
Fluoxetine Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Triamterene.
Nimodipine Nimodipine The risk or severity of hyperkalemia can be increased when Triamterene is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Triamterene can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The metabolism of Triamterene can be decreased when combined with Clozapine.
Estazolam Estazolam Triamterene may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin The metabolism of Triamterene can be decreased when combined with Ofloxacin.
Didanosine Didanosine Triamterene may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Triamterene may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Benazepril.
Etodolac Etodolac The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Etodolac is combined with Triamterene.
Felodipine Felodipine The risk or severity of hyperkalemia can be increased when Triamterene is combined with Felodipine.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Fosinopril.
Nabumetone Nabumetone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Triamterene.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Quinapril.
Ramipril Ramipril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Ramipril.
Amlodipine Amlodipine The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Triamterene.
Itraconazole Itraconazole The risk or severity of hyperkalemia can be increased when Triamterene is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Lisinopril.
Oxaprozin Oxaprozin The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Triamterene.
Sotalol Sotalol The risk or severity of hyperkalemia can be increased when Triamterene is combined with Sotalol.
Bisoprolol Bisoprolol Triamterene may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Triamterene.
Doxazosin Doxazosin The risk or severity of adverse effects can be increased when Triamterene is combined with Doxazosin.
Terazosin Terazosin The risk or severity of adverse effects can be increased when Triamterene is combined with Terazosin.
Isradipine Isradipine Isradipine may decrease the excretion rate of Triamterene which could result in a higher serum level.
Omeprazole Omeprazole The metabolism of Triamterene can be increased when combined with Omeprazole.
Venlafaxine Venlafaxine Triamterene may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
Fluvoxamine Fluvoxamine The metabolism of Triamterene can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone Triamterene may decrease the excretion rate of Nefazodone which could result in a higher serum level.
Lamotrigine Lamotrigine Triamterene may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Losartan Losartan The risk or severity of hyperkalemia can be increased when Losartan is combined with Triamterene.
Valacyclovir Valacyclovir The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Valaciclovir.
Tramadol Tramadol The therapeutic efficacy of Triamterene can be decreased when used in combination with Tramadol.
Carboplatin Injection Carboplatin Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Carboplatin.
Moexipril Moexipril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Moexipril.
Ifosfamide Injection Ifosfamide Injection Triamterene may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine Nicardipine The risk or severity of hyperkalemia can be increased when Triamterene is combined with Nicardipine.
Bupropion Bupropion Triamterene may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Triamterene can be decreased when combined with Ticlopidine.
Metformin Metformin Triamterene may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Triamterene is combined with Dalteparin.
Nisoldipine Nisoldipine Triamterene may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine Lamivudine Triamterene may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Triamterene.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Triamterene is combined with Amifostine.
Acarbose Acarbose Triamterene may decrease the excretion rate of Acarbose which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Triamterene may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Ritonavir Ritonavir The metabolism of Triamterene can be increased when combined with Ritonavir.
Cidofovir Injection Cidofovir Injection The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Triamterene.
Meropenem Injection Meropenem Injection Triamterene may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Triamterene.
Zafirlukast Zafirlukast The metabolism of Triamterene can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Triamterene may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The metabolism of Triamterene can be decreased when combined with Mirtazapine.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Triamterene is combined with Trandolapril.
Topiramate Topiramate Triamterene may decrease the excretion rate of Topiramate which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Triamterene.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Triamterene.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Triamterene can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Triamterene may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Carvedilol Carvedilol The metabolism of Carvedilol can be decreased when combined with Triamterene.
Nilutamide Nilutamide Triamterene may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be decreased when combined with Triamterene.
Selegiline Selegiline Selegiline may increase the orthostatic hypotensive activities of Triamterene.
Propafenone Propafenone The metabolism of Triamterene can be decreased when combined with Propafenone.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Triamterene.
Tamsulosin Tamsulosin Triamterene may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Triamterene.
Quetiapine Quetiapine Triamterene may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefepime.
Cefprozil Cefprozil The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefprozil.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefpodoxime.
Cetirizine Cetirizine Triamterene may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The metabolism of Paroxetine can be decreased when combined with Triamterene.
Tolcapone Tolcapone Triamterene may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The metabolism of Triamterene can be decreased when combined with Citalopram.
Capecitabine Capecitabine Triamterene may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The metabolism of Triamterene can be decreased when combined with Efavirenz.
Abacavir Abacavir Triamterene may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The risk or severity of hypotension can be increased when Sildenafil is combined with Triamterene.
Celecoxib Celecoxib The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Celecoxib is combined with Triamterene.
Rosiglitazone Rosiglitazone The metabolism of Triamterene can be decreased when combined with Rosiglitazone.
Tolterodine Tolterodine Triamterene may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Triamterene is combined with Thalidomide.
Oseltamivir Oseltamivir Triamterene may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Balsalazide Balsalazide The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Balsalazide is combined with Triamterene.
Nateglinide Nateglinide Triamterene may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Triamterene may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be decreased when combined with Triamterene.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists